DermTech to Explore Strategic Alternatives and Implement Restructuring Plan
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
- Microsoft to offer buyouts to 60,000 workers in cost-cutting move - Bloomberg
- S&P Global explores potential separation of Capital IQ business
- JetBlue shares drop on creditor restructuring news amid bankruptcy filing fears
- Celestica (CLS) Tops Q3 EPS by 31c, Offers Guidance
- Equities end higher as Anthropic's IPO filing buoys AI stocks
Lake Street Capital Markets Downgrades DermTech Inc. (DMTK) to Hold
April 19, 2024 7:29 AM EDTLake Street Capital Markets analyst Thomas Flaten downgraded DermTech Inc. (NASDAQ: DMTK) from Buy to Hold with a price target of $0.63.
For an analyst ratings summary and ratings history on DermTech Inc. click here. For more ratings news on DermTech Inc. click here.
Shares of DermTech Inc. closed at $0.59 yesterday.
... MoreBTIG Downgrades DermTech Inc. (DMTK) to Neutral
April 19, 2024 6:03 AM EDTBTIG analyst Sung Ji Nam downgraded DermTech Inc. (NASDAQ: DMTK) from Buy to Neutral.
The analyst comments "After the market close, DermTech announced that it has initiated a formal strategic review process. DMTK will consider all strategic options, including an acquisition, merger, reverse merger, business combination, licensing, sale of assets, or other transaction. In addition, DMTK announced it is again reducing its workforce, this time by 56%, or by ~100 employees. We spoke to the company following its... More



